SecBot SecBot
8-K ·Filed May 29, 2026

VREOF

Vireo Growth Inc.
MIXED
Impact 6/10
Horizonweeks Processed5mo ago SEC0001104659-26-068242
8-K material event: Items 1.01
Actionable Insight ◆ Mixed

The acquisition converts a lease liability into owned real estate but at a high cost, $49M at 15% interest alone implies ~$7.4M annual interest on the seller note. Monitor the next 10-Q for debt service coverage ratios and whether the facility's cash flow can support the combined interest burden. The two-year maturity on the seller note creates refinancing risk in 2027.

DirectionMixed
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$13.05
T+0 close · May 29, 2026 · via day close
Latest settled
−17.61%
T+60 · $10.75
Vs SPY
−18.84%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 1 $13.05entry
  2. T+1 · 6mo ago −3.15%α −3.30% · $12.64
  3. T+5 · 5mo ago −2.51%α +0.24% · $12.72
  4. T+20 · 5mo ago −23.47%α −22.17% · $9.99
  5. T+60 · 3mo ago −17.61%α −18.84% · $10.75

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Vireo Growth exercised its purchase option to acquire a 389,000 sq ft cannabis cultivation facility in Perth, NY from an IIP subsidiary for $88.5M. The deal was funded by a $49M seller-financed note (15% interest, matures May 2027) and a $41M second-lien loan from Chicago Atlantic (prime + 5.75%, matures May 2028). The company now owns the facility free of lease obligations but carries $90M in new secured debt with aggressive interest costs.

Key Financial Metrics

Deal Value
$88.5M
Deal Type
acquisition

Key Facts

  • Acquired 389,000 sq ft cannabis cultivation facility in Perth, NY for $88.5M from IIP-NY 2 LLC (IIP subsidiary)
  • Seller financing: $49M note at 15% interest, interest-only monthly, matures May 25, 2027, with two 1-year extension options (1% fee each)
  • Chicago Atlantic loan: $41M at prime + 5.75%, matures May 28, 2028, second-priority lien subordinated to seller note
  • Total new debt: $90M ($49M + $41M) secured by the property; company and subsidiary provide guarantees
  • Previously leased facility, acquisition eliminates lease obligations but adds significant debt service burden

Financial Impact

$88.5M asset acquisition funded by $90M in new debt ($49M at 15% + $41M at prime+5.75%)

debtinterest_expenseleverage

Risk Factors

  • High interest cost ($49M at 15% + $41M at prime+5.75%) may strain cash flow
  • Seller note matures May 2027, refinancing risk if cannabis credit markets tighten
  • Cross-default provisions between the two loans could trigger acceleration
  • Cannabis industry regulatory and federal illegality risks remain

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-068242
Document: tm2615959d1_ex99-1.htm0001104659-26-068242
Document: 0001104659-26-068242-index-headers.html0001104659-26-068242
Document: 0001104659-26-068242-index.html0001104659-26-068242
Document: 0001104659-26-068242.txt0001104659-26-068242

US Market Status

Market Closed · Opens in 6h 5m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 29, 2026